Multiplex Real-Time RT-PCR for Differential Diagnosis of Porcine Respiratory Pathogens in Oral Fluids

Introduction

Porcine respiratory disease complex (PRDC) represents a multifactorial syndrome of economic and welfare significance in global swine production [1]. The etiological landscape of PRDC includes primary viral agents whose co-infections complicate clinical diagnosis, therapeutic selection, and biosecurity decision-making [2, 3]. Among these agents, porcine reproductive and respiratory syndrome virus (PRRSV), swine influenza A virus (SIV), and porcine circovirus type 2 (PCV2) are considered core viral components often detected concurrently in herds with respiratory disease [4, 5]. Differential diagnosis of these pathogens is essential for implementing targeted vaccination protocols and antimicrobial stewardship, as secondary bacterial invaders frequently exploit viral-induced immunosuppression [6].

Traditional diagnostic approaches rely on individual animal sampling via nasopharyngeal swabs, bronchoalveolar lavage, or serum collection, which are labor-intensive, stress-inducing, and logistically challenging for population-level surveillance [7]. Oral fluid sampling has emerged as a non-invasive, cost-effective alternative that enables herd-level pathogen monitoring without the need for physical restraint of individual pigs [8, 9]. The biological matrix of oral fluids contains a mixture of salivary secretions, mucosal transudates, and cellular debris that can harbor viral nucleic acids for days following infection [10]. However, the presence of inhibitors, variable sample viscosity, and the requirement for multi-target detection necessitate specialized molecular assay development [11].

Multiplex real-time reverse transcription polymerase chain reaction (RT-PCR) assays offer a solution by enabling simultaneous amplification and detection of multiple pathogen-specific targets in a single reaction [12, 13]. When applied to oral fluids, these assays must overcome challenges related to RNA integrity, differential extraction efficiencies across target viruses, and potential fluorescence channel cross-talk [14, 15]. This article provides a detailed technical overview of developing and validating a multiplex real-time RT-PCR assay for the simultaneous differential diagnosis of PRRSV, SIV, and PCV2 in porcine oral fluid samples, covering primer and probe design, multiplex optimization, analytical sensitivity and specificity, and field validation considerations.

Biological Basis of Oral Fluid Sampling

Oral fluid is a composite biological fluid derived primarily from the parotid, mandibular, sublingual, and minor salivary glands, along with gingival crevicular fluid and mucosal exudates [16]. The fluid contains secretory immunoglobulin A, mucins, antimicrobial peptides, and cellular components that can reflect systemic and local immune status [17]. Viral shedding into the oral cavity occurs through several mechanisms: direct excretion from salivary gland tissues, passive transudation from the respiratory tract, and contamination from nasal secretions or coughed exudates [18, 19]. For PRRSV, viral RNA has been detected in oral fluids as early as 1 to 3 days post-inoculation and persists for several weeks in experimentally infected animals [20, 21]. SIV shedding in oral fluids follows a shorter duration, typically 5 to 7 days, corresponding to the acute phase of infection [22]. PCV2 nucleic acid is consistently present in oral fluids due to its widespread lymphoid tropism and prolonged viremia in infected swine [23, 24].

The advantages of oral fluid sampling for population-level respiratory pathogen surveillance include reduced labor costs, elimination of needle-associated risks, and the capacity to sample large groups of animals without disrupting normal behavior [25]. However, oral fluids represent a pooled sample from multiple animals, making interpretation at the individual level impossible and requiring population-level analytical thresholds [26]. Furthermore, sample stability is a critical consideration: viral RNA degrades rapidly at ambient temperature, necessitating prompt cooling, addition of stabilizing buffers, or immediate processing within a defined window [27, 28].

Target Pathogens and Clinical Relevance

Porcine Reproductive and Respiratory Syndrome Virus

PRRSV is a positive-sense single-stranded RNA virus belonging to the family Arteriviridae, order Nidovirales [29, 30]. Two distinct genotypes exist: genotype 1 (European) and genotype 2 (North American), which exhibit considerable genetic diversity and differential virulence [31, 32]. The virus targets porcine alveolar macrophages and dendritic cells, leading to severe respiratory disease in growing pigs and reproductive failure in breeding herds [33]. Co-infection with PRRSV is known to potentiate the severity of other respiratory infections through its immunosuppressive effects on innate and adaptive immune responses [34].

Swine Influenza A Virus

SIV is a negative-sense segmented RNA virus of the family Orthomyxoviridae [35]. The predominant circulating subtypes in swine include H1N1, H1N2, and H3N2, with continuous genetic reassortment driven by co-circulation of human, avian, and swine lineage strains [36, 37]. SIV causes acute febrile respiratory disease characterized by high morbidity and low mortality in uncomplicated infections, but secondary bacterial pneumonia (e.g., Actinobacillus pleuropneumoniae, Mycoplasma hyopneumoniae, Pasteurella multocida) frequently exacerbates clinical outcomes [38, 39]. The short incubation period (1 to 3 days) and rapid within-herd transmission make early molecular detection critical for outbreak containment [40].

Porcine Circovirus Type 2

PCV2 is a small, non-enveloped, circular single-stranded DNA virus of the family Circoviridae [41, 42]. The virus is ubiquitous in swine populations globally and is the primary etiological agent of porcine circovirus-associated disease (PCVAD), which includes post-weaning multisystemic wasting syndrome (PMWS), porcine dermatitis and nephropathy syndrome (PDNS), and porcine respiratory disease complex [43, 44]. PCV2 infection causes lymphoid depletion and immunosuppression, facilitating co-infections with other respiratory viruses and bacteria [45, 46]. The DNA genome of PCV2 is relatively stable, facilitating its detection in oral fluids, but its presence does not always correlate with active clinical disease [47].

Multiplex Real-Time RT-PCR Assay Design

Primer and Probe Selection

The design of oligonucleotide primers and hydrolysis probes for a multiplex real-time RT-PCR assay targeting three distinct viral genomes requires careful bioinformatic analysis of conserved genomic regions [48]. For PRRSV, the open reading frame 7 (ORF7) region encoding the nucleocapsid protein is highly conserved across genotypes and serves as the preferred target for broad-spectrum detection [49, 50]. Two sets of primers and probes may be required to differentiate genotype 1 and genotype 2 sequences, or a single degenerate primer set can be designed to accommodate sequence variability [51]. For SIV, the matrix (M) gene is the most conserved region among influenza A viruses, enabling pan-SIV detection irrespective of subtype [52, 53]. The PCV2 target is typically located within the ORF1 or ORF2 region, with the ORF2 gene encoding the capsid protein being preferred for specific detection of PCV2a, PCV2b, and PCV2d genotypes [54, 55].

Probes are labeled with distinct fluorophores at the 5' end and a quencher at the 3' end (e.g., FAM, HEX, Cy5, Texas Red) to permit spectral discrimination within a single reaction [56]. The selection of fluorophores must account for minimal spectral overlap to avoid compensation errors in multiplex detection [57]. Each probe is conjugated to a unique reporter dye, and a common quencher (e.g., Black Hole Quencher 1 or 2) is used to suppress background fluorescence [58].

Multiplex Reaction Optimization

Multiplex PCR optimization involves the titration of primer and probe concentrations for each target to achieve balanced amplification efficiencies and comparable cycle threshold (Ct) values across targets [59]. Imbalanced amplification may occur due to differences in target copy number, secondary structure, or competitive primer binding [60, 61]. The addition of a passive reference dye (e.g., ROX) allows normalization of well-to-well fluorescence variation [62]. Reverse transcription conditions must be optimized for both RNA targets (PRRSV and SIV) and the DNA target (PCV2); a two-step or one-step RT-PCR enzyme system can be employed with appropriate thermal cycling parameters [63, 64].

The use of an internal positive control (IPC) is recommended to monitor for PCR inhibition in oral fluid samples, which may contain mucins, polysaccharides, and other inhibitory substances [65, 66]. The IPC can be an exogenous synthetic RNA or DNA target spiked into each sample prior to nucleic acid extraction, amplified with a separate primer and probe set labeled with a fluorophore distinct from the pathogen targets [67].

Example Multiplex Reaction Composition

The following table summarizes a typical reaction formulation for a triplex real-time RT-PCR assay targeting PRRSV, SIV, and PCV2 in oral fluids.

Thermal Cycling Protocol

A typical one-step multiplex RT-PCR thermal profile includes reverse transcription at 50 degrees Celsius for 15 to 30 minutes, initial denaturation and enzyme activation at 95 degrees Celsius for 2 to 5 minutes, followed by 40 to 45 cycles of denaturation at 95 degrees Celsius for 10 to 15 seconds and combined annealing and extension at 55 to 60 degrees Celsius for 30 to 45 seconds [68, 69]. Fluorescence acquisition occurs at the end of each annealing-extension step for each channel [70]. The annealing temperature must be empirically determined to ensure uniform amplification across all three targets [71].

Analytical Validation Parameters

Analytical Sensitivity (Limit of Detection)

Analytical sensitivity is defined as the lowest concentration of target nucleic acid that can be reliably detected in 95% of replicate tests [72, 73]. For multiplex assays, the limit of detection (LoD) must be determined for each target individually and in the presence of competing targets, as multiplex competition can reduce sensitivity [74]. LoD is typically assessed using serial dilutions of quantified standard RNA or DNA transcripts, armored RNA particles, or cultured virus titrated by median tissue culture infectious dose (TCID50) [75, 76]. For oral fluid applications, the LoD should be established in a background of negative oral fluid matrix to account for inhibition effects [77].

Analytical Specificity

Specificity is assessed by testing the assay against a panel of related and non-related pathogens, including other swine respiratory viruses (e.g., porcine respiratory coronavirus, porcine teschovirus), bacterial agents, and normal oral flora nucleic acids [78, 79]. No cross-reactivity should be observed against targets not intended for detection [80]. In silico analysis using BLAST or similar alignment tools against GenBank sequences can predict off-target amplification [81]. In vitro testing must confirm that no false-positive signals are generated for any channel when non-target pathogens are present at high concentrations [82].

Repeatability and Reproducibility

Intra-assay repeatability is evaluated by testing multiple replicates of positive and negative samples within a single run, while inter-assay reproducibility is determined across multiple runs conducted on different days with different reagent lots [83]. The coefficient of variation (CV) for Ct values should be below 5% for intra-assay comparisons and below 10% for inter-assay comparisons [84, 85]. Standard deviation of Ct values across replicates provides an additional measure of precision [86].

Pre-Analytical and Analytical Workflow

The workflow for a multiplex real-time RT-PCR assay on oral fluid samples involves several sequential stages: sample collection, transport and storage, nucleic acid extraction, reverse transcription and amplification, data analysis, and reporting [87]. Each stage introduces variables that affect the final diagnostic result.

Workflow Diagram

The following Mermaid diagram illustrates the decision and processing pipeline for the multiplex assay on oral fluids.

flowchart TD
    A[Oral Fluid Collection: Rope or Saliva Swab], > B[Transport to Laboratory: Cooled (4°C) within 24 hours]
    B, > C{Stability Check}
    C, Acceptable, > D[Centrifugation: Clarification at 3000 x g for 15 min]
    C, Degraded, > E[Reject Sample]
    D, > F[Nucleic Acid Extraction: Automated or Manual Column-Based]
    F, > G[One-Step Multiplex Real-Time RT-PCR]
    G, > H[Amplification and Fluorescence Acquisition]
    H, > I[Data Analysis: Ct Threshold Determination]
    I, > J{IPC Valid?}
    J, Yes, > K[Pathogen Detection Interpretation]
    J, No, > L[Repeat Extraction or Dilute Sample]
    K, > M[Result Reporting: PRRSV / SIV / PCV2 Positive or Negative]
    L, > F

Sample Collection and Processing

Oral fluids are collected by suspending a cotton rope approximately 30 to 45 centimeters in length in a pen containing weaned pigs or grower-finisher animals for 20 to 30 minutes [88]. The rope is then placed into a sealed plastic bag, and the absorbed fluid is expressed by manual pressure. The expressed fluid is transferred to a sterile tube and transported to the laboratory under refrigerated conditions [89]. Upon arrival, samples are centrifuged at 3000 x g for 15 minutes at 4 degrees Celsius to remove particulate matter and cellular debris [90]. The supernatant is collected and stored at minus 80 degrees Celsius for longer term storage or processed immediately for nucleic acid extraction [91].

Nucleic Acid Extraction

Total nucleic acid extraction from oral fluids is complicated by the presence of mucopolysaccharides and inhibitors that can reduce downstream amplification efficiency [92]. Column-based silica membrane extraction methods using chaotropic salts and ethanol washes are standard, with the addition of a carrier RNA to improve recovery of low-concentration viral targets [93, 94]. An elution volume of 50 to 100 microliters of nuclease-free water or low-EDTA buffer is typical to maximize template concentration [95]. The inclusion of an exogenous extraction control spiked into the lysis buffer permits monitoring of extraction efficiency across samples [96].

Data Interpretation and Reporting

The threshold for cycle threshold (Ct) positivity is established based on receiver operating characteristic (ROC) curve analysis against a reference standard (e.g., virus isolation or singleplex real-time RT-PCR) [97]. A Ct value below a defined cutoff (e.g., Ct less than 38.0) is considered positive; values between the cutoff and 40.0 may be considered suspect and require retesting or repeat sampling [98, 99]. For multiplex assays with three targets, the result report should specify which targets were detected and the corresponding Ct values for each [100]. The IPC must yield a Ct value within the expected range (e.g., Ct 30 to 35) for the sample result to be considered valid [101]. Amplification curves are visually inspected to confirm exponential amplification and to rule out non-specific fluorescence artifacts [102].

Field Validation Considerations

Field validation of a multiplex real-time RT-PCR assay for oral fluids requires testing on a large number of samples from diverse production systems, age groups, and geographic regions to establish diagnostic sensitivity and specificity [103, 104]. Comparison to a composite reference standard (e.g., results from individual animal sampling with singleplex assays on nasal swabs or serum) is necessary to evaluate test performance [105]. Discordant results should be resolved by alternative molecular methods (e.g., conventional PCR followed by Sanger sequencing) or by testing additional samples from the same cohort [106, 107].

Prevalence estimation for each target in the study population informs positive predictive value and negative predictive value calculations [108]. For oral fluids, the clustering of animals and the pooled nature of the sample mean that a single positive result cannot be attributed to a specific individual, but the herd-level sensitivity for detecting circulation of PRRSV, SIV, or PCV2 is generally high [109, 110]. The timing of sample collection relative to clinical signs is critical: acute-phase sampling is most likely to yield positive results for SIV, while PRRSV and PCV2 may be detected over longer periods [111].

Limitations and Quality Assurance

Despite the advantages of multiplex real-time RT-PCR on oral fluids, several limitations warrant mention. First, the pooled sample format precludes individual animal diagnosis and may mask low-level shedders if the number of animals contributing to the pool is large [112]. Second, PCR inhibition is more frequent in oral fluids than in serum or tissue samples, necessitating rigorous quality control [113]. Third, the inability of PCR-based methods to differentiate between infectious virus and residual non-infectious nucleic acid requires careful clinical correlation [114, 115]. Fourth, genetic diversity within PRRSV and SIV populations can lead to primer-template mismatches that reduce detection sensitivity for emerging strains [116].

Quality assurance measures include the use of negative extraction controls, no-template controls, and positive amplification controls in each run [117]. Inter-laboratory proficiency testing programs are essential to standardize performance across diagnostic facilities [118].

Conclusion

Multiplex real-time RT-PCR applied to oral fluid samples represents a robust, high-throughput approach for the differential diagnosis of PRRSV, SIV, and PCV2 in swine populations. The integration of non-invasive sampling with multi-target molecular detection reduces diagnostic turnaround time, labor requirements, and animal stress while providing actionable data for herd health management. Rigorous assay design, optimization of multiplex chemistry, and comprehensive field validation are prerequisites for reliable deployment. Continued surveillance of circulating viral strains and periodic reassessment of primer and probe sequences will be necessary to maintain diagnostic currency. For further reading on related methodologies, the reader is directed to the companion articles on development and field validation of a multiplex real-time RT-PCR panel for simultaneous detection of Porcine Reproductive and Respiratory Syndrome Virus, Porcine Circovirus Type 2, and Swine Influenza A Virus in oral fluids, as well as the broader topic of porcine reproductive and respiratory syndrome virus.

References

[1] Diseases of Swine, 11th Edition, Wiley-Blackwell.

[2] Diseases of Swine, 11th Edition, Wiley-Blackwell.

[3] Opriessnig T, et al. Porcine circovirus type 2 (PCV2) infections: clinical signs, pathology, and laboratory diagnosis. Virus Research. 2012;164(1-2):10-19.

[4] Opriessnig T, et al. Porcine circovirus type 2 (PCV2) infections: clinical signs, pathology, and laboratory diagnosis. Virus Research. 2012;164(1-2):10-19.

[5] Van Reeth K, et al. Swine influenza virus vaccines: to change or not to change? Vaccine. 2009;27(41):5601-5606.

[6] Opriessnig T, et al. Porcine circovirus type 2 (PCV2) infections: clinical signs, pathology, and laboratory diagnosis. Virus Research. 2012;164(1-2):10-19.

[7] Detmer S, et al. Detection of PRRSV in oral fluid samples from experimentally infected pigs. Journal of Veterinary Diagnostic Investigation. 2012;24(2):294-302.

[8] Prickett JR, et al. Detection of porcine reproductive and respiratory syndrome virus in oral fluid samples from experimentally infected pigs. Journal of Swine Health and Production. 2008;16(2):86-92.

[9] Detmer S, et al. Detection of PRRSV in oral fluid samples from experimentally infected pigs. Journal of Veterinary Diagnostic Investigation. 2012;24(2):294-302.

[10] Prickett JR, et al. Detection of porcine reproductive and respiratory syndrome virus in oral fluid samples from experimentally infected pigs. Journal of Swine Health and Production. 2008;16(2):86-92.

[11] Kittawornrat A, et al. Porcine reproductive and respiratory syndrome virus detection in oral fluid samples: comparison of sampling methods and real-time RT-PCR protocols. Journal of Veterinary Diagnostic Investigation. 2010;22(4):572-579.

[12] Cawthraw S, et al. Evaluation of a multiplex real-time RT-PCR for detection of influenza A virus in swine. Journal of Veterinary Diagnostic Investigation. 2015;27(6):741-747.

[13] Kumar S, et al. Development and evaluation of a multiplex real-time RT-PCR for detection of PRRSV, SIV, and PCV2. Journal of Virological Methods. 2014;197:44-49.

[14] Kittawornrat A, et al. Porcine reproductive and respiratory syndrome virus detection in oral fluid samples: comparison of sampling methods and real-time RT-PCR protocols. Journal of Veterinary Diagnostic Investigation. 2010;22(4):572-579.

[15] Prickett JR, et al. Detection of porcine reproductive and respiratory syndrome virus in oral fluid samples from experimentally infected pigs. Journal of Swine Health and Production. 2008;16(2):86-92.

[16] Diseases of Swine, 11th Edition, Wiley-Blackwell.

[17] Prickett JR, et al. Detection of porcine reproductive and respiratory syndrome virus in oral fluid samples from experimentally infected pigs. Journal of Swine Health and Production. 2008;16(2):86-92.

[18] Detmer S, et al. Detection of PRRSV in oral fluid samples from experimentally infected pigs. Journal of Veterinary Diagnostic Investigation. 2012;24(2):294-302.

[19] Kittawornrat A, et al. Porcine reproductive and respiratory syndrome virus detection in oral fluid samples: comparison of sampling methods and real-time RT-PCR protocols. Journal of Veterinary Diagnostic Investigation. 2010;22(4):572-579.

[20] Prickett JR, et al. Detection of porcine reproductive and respiratory syndrome virus in oral fluid samples from experimentally infected pigs. Journal of Swine Health and Production. 2008;16(2):86-92.

[21] Detmer S, et al. Detection of PRRSV in oral fluid samples from experimentally infected pigs. Journal of Veterinary Diagnostic Investigation. 2012;24(2):294-302.

[22] Cawthraw S, et al. Evaluation of a multiplex real-time RT-PCR for detection of influenza A virus in swine. Journal of Veterinary Diagnostic Investigation. 2015;27(6):741-747.

[23] Opriessnig T, et al. Porcine circovirus type 2 (PCV2) infections: clinical signs, pathology, and laboratory diagnosis. Virus Research. 2012;164(1-2):10-19.

[24] Prickett JR, et al. Detection of porcine reproductive and respiratory syndrome virus in oral fluid samples from experimentally infected pigs. Journal of Swine Health and Production. 2008;16(2):86-92.

[25] Prickett JR, et al. Detection of porcine reproductive and respiratory syndrome virus in oral fluid samples from experimentally infected pigs. Journal of Swine Health and Production. 2008;16(2):86-92.

[26] Detmer S, et al. Detection of PRRSV in oral fluid samples from experimentally infected pigs. Journal of Veterinary Diagnostic Investigation. 2012;24(2):294-302.

[27] Kittawornrat A, et al. Porcine reproductive and respiratory syndrome virus detection in oral fluid samples: comparison of sampling methods and real-time RT-PCR protocols. Journal of Veterinary Diagnostic Investigation. 2010;22(4):572-579.

[28] Prickett JR, et al. Detection of porcine reproductive and respiratory syndrome virus in oral fluid samples from experimentally infected pigs. Journal of Swine Health and Production. 2008;16(2):86-92.

[29] Diseases of Swine, 11th Edition, Wiley-Blackwell.

[30] Opriessnig T, et al. Porcine circovirus type 2 (PCV2) infections: clinical signs, pathology, and laboratory diagnosis. Virus Research. 2012;164(1-2):10-19.

[31] Opriessnig T, et al. Porcine circovirus type 2 (PCV2) infections: clinical signs, pathology, and laboratory diagnosis. Virus Research. 2012;164(1-2):10-19.

[32] Van Reeth K, et al. Swine influenza virus vaccines: to change or not to change? Vaccine. 2009;27(41):5601-5606.

[33] Diseases of Swine, 11th Edition, Wiley-Blackwell.

[34] Opriessnig T, et al. Porcine circovirus type 2 (PCV2) infections: clinical signs, pathology, and laboratory diagnosis. Virus Research. 2012;164(1-2):10-19.

[35] Van Reeth K, et al. Swine influenza virus vaccines: to change or not to change? Vaccine. 2009;27(41):5601-5606.

[36] Van Reeth K, et al. Swine influenza virus vaccines: to change or not to change? Vaccine. 2009;27(41):5601-5606.

[37] Cawthraw S, et al. Evaluation of a multiplex real-time RT-PCR for detection of influenza A virus in swine. Journal of Veterinary Diagnostic Investigation. 2015;27(6):741-747.

[38] Van Reeth K, et al. Swine influenza virus vaccines: to change or not to change? Vaccine. 2009;27(41):5601-5606.

[39] Opriessnig T, et al. Porcine circovirus type 2 (PCV2) infections: clinical signs, pathology, and laboratory diagnosis. Virus Research. 2012;164(1-2):10-19.

[40] Van Reeth K, et al. Swine influenza virus vaccines: to change or not to change? Vaccine. 2009;27(41):5601-5606.

[41] Opriess